EcoDrugPlus

High Mobility Group Box 1

Ensembl ID : ENSCGOG00000001624
Gene Symbol: HMGB1
2 Cross references
498 Possible Orthologues:

High Mobility Group-T Protein-Like

Ensembl ID : ENSCGOG00000009631
Gene Symbol: LOC115018099
3 Cross references
512 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSCGOG00000023840
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSCGOG00000024501
Gene Symbol: HRH2
3 Cross references
181 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSCGOG00000009139
Gene Symbol: HRH2A
1 Cross references
192 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSCGOG00000022340
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSCGOG00000003367
Gene Symbol: HDAC11
3 Cross references
200 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSCGOG00000014421
Gene Symbol: HDAC2
1 Cross references
206 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSCGOG00000019273
Gene Symbol: HDAC4
3 Cross references
196 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSCGOG00000013392
Gene Symbol: LOC115026165
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSCGOG00000020048
Gene Symbol: HDAC5
3 Cross references
195 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSCGOG00000023547
Gene Symbol: HDAC7
3 Cross references
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).